GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EMC Instytut Medyczny SA (WAR:EMC) » Definitions » 3-Year RORE %

EMC Instytut Medyczny (WAR:EMC) 3-Year RORE % : 112.69% (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is EMC Instytut Medyczny 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. EMC Instytut Medyczny's 3-Year RORE % for the quarter that ended in Mar. 2024 was 112.69%.

The industry rank for EMC Instytut Medyczny's 3-Year RORE % or its related term are showing as below:

WAR:EMC's 3-Year RORE % is ranked better than
92.71% of 590 companies
in the Healthcare Providers & Services industry
Industry Median: -0.68 vs WAR:EMC: 112.69

EMC Instytut Medyczny 3-Year RORE % Historical Data

The historical data trend for EMC Instytut Medyczny's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EMC Instytut Medyczny 3-Year RORE % Chart

EMC Instytut Medyczny Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.42 -41.79 -57.43 -102.43 123.01

EMC Instytut Medyczny Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -257.63 1,764.71 295.12 123.01 112.69

Competitive Comparison of EMC Instytut Medyczny's 3-Year RORE %

For the Medical Care Facilities subindustry, EMC Instytut Medyczny's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EMC Instytut Medyczny's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EMC Instytut Medyczny's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where EMC Instytut Medyczny's 3-Year RORE % falls into.



EMC Instytut Medyczny 3-Year RORE % Calculation

EMC Instytut Medyczny's 3-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.406--0.1 )/( 0.449-0 )
=0.506/0.449
=112.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 3-year before.


EMC Instytut Medyczny  (WAR:EMC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


EMC Instytut Medyczny 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of EMC Instytut Medyczny's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


EMC Instytut Medyczny (WAR:EMC) Business Description

Traded in Other Exchanges
N/A
Address
ul. Pilczycka 144-148, Wroclaw, POL, 54-144
EMC Instytut Medyczny SA owns and operates hospitals and clinics in Poland. It offers specialized advice, full diagnostics, hospital treatment, care for older people in specialized centers or home conditions. It also offers services including private medical care, specialized consultations, primary health care, outpatient rehabilitation, long-term care and 24hours medical europaservice.

EMC Instytut Medyczny (WAR:EMC) Headlines

From GuruFocus

John Paulson Goes Virtual

By Sydnee Gatewood Sydnee Gatewood 08-16-2016

A Few Reasons to Invest in EMC for the Long Run

By techjunk13 techjunk13 12-05-2014

EMC Is All Set to Profit From Growing Data Storage Solutions

By rusticnomad rusticnomad 06-20-2014

David Rolfe Comments on EMC

By Holly LaFon 10-15-2015

Dell-EMC is Not a Done Deal

By Renee Ann Butler Renee Ann Butler 12-03-2015

Eric Mindich Makes 10 New Buys in 4th Quarter

By David Goodloe David Goodloe 03-07-2016

David Einhorn's Best Stocks of 2014

By Holly LaFon Holly LaFon 12-27-2014

Here's Why EMC Looks Like a Good Prospect

By RHPanalysts RHPanalysts 09-21-2014

Seth Klarman Adds to Stake in EMC

By Kyle Ferguson Kyle Ferguson 06-26-2016